Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$44.00
-0.05-0.11%
At close: -
$44.00
0.000.00%
After Hours: May 23, 4:00 PM EDT
Comments
Loading...
Mirum Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:MIRM | Benzinga
Mirum Pharmaceuticals Inc has a consensus price target of $59.82 based on the ratings of 17 analysts. The high is $77 issued by Raymond James on May 13, 2025. The low is $38 issued by Citigroup on May 9, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Raymond James, and JMP Securities on May 19, 2025, May 13, 2025, and May 9, 2025, respectively. With an average price target of $75.33 between HC Wainwright & Co., Raymond James, and JMP Securities, there's an implied 71.21% upside for Mirum Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Raymond James
JMP Securities
HC Wainwright & Co.
Baird
1calculated from analyst ratings
Analyst Ratings for Mirum Pharmaceuticals
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/19/2025 | Buy Now | 65.91% | HC Wainwright & Co. | Swayampakula Ramakanth50% | → $73 | Assumes | → Buy | Get Alert |
| 05/13/2025 | Buy Now | 75% | Raymond James | Steven Seedhouse58% | $73 → $77 | Maintains | Strong Buy | Get Alert |
| 05/09/2025 | Buy Now | 72.73% | JMP Securities | Jonathan Wolleben68% | $74 → $76 | Maintains | Market Outperform | Get Alert |
| 02/28/2025 | Buy Now | 63.64% | HC Wainwright & Co. | Ed Arce59% | $66 → $72 | Maintains | Buy | Get Alert |
| 02/27/2025 | Buy Now | 25% | Baird | Brian Skorney57% | $50 → $55 | Maintains | Outperform | Get Alert |
| 02/24/2025 | Buy Now | 68.18% | Citizens Capital Markets | Jonathan Wolleben68% | $74 → $74 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/13/2024 | Buy Now | 50% | HC Wainwright & Co. | Ed Arce59% | $66 → $66 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | Buy Now | 54.55% | Citigroup | David Lebowitz53% | $65 → $68 | Maintains | Buy | Get Alert |
| 11/13/2024 | Buy Now | 13.64% | Baird | Brian Skorney57% | $44 → $50 | Maintains | Outperform | Get Alert |
| 10/17/2024 | Buy Now | 11.36% | Leerink Partners | Mani Foroohar47% | $47 → $49 | Maintains | Outperform | Get Alert |
| 10/11/2024 | Buy Now | 50% | HC Wainwright & Co. | Ed Arce59% | $66 → $66 | Reiterates | Buy → Buy | Get Alert |
| 08/08/2024 | Buy Now | 36.36% | Cantor Fitzgerald | Josh Schimmer52% | $50 → $60 | Maintains | Overweight | Get Alert |
| 08/08/2024 | Buy Now | 50% | Evercore ISI Group | Gavin Clark-Gartner38% | $62 → $66 | Maintains | Outperform | Get Alert |
| 08/08/2024 | Buy Now | — | Baird | Brian Skorney57% | $39 → $44 | Maintains | Outperform | Get Alert |
| 07/26/2024 | Buy Now | 50% | HC Wainwright & Co. | Ed Arce59% | $66 → $66 | Reiterates | Buy → Buy | Get Alert |
| 07/08/2024 | Buy Now | 50% | HC Wainwright & Co. | Ed Arce59% | $66 → $66 | Reiterates | Buy → Buy | Get Alert |
| 06/28/2024 | Buy Now | 50% | HC Wainwright & Co. | Ed Arce59% | $66 → $66 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2024 | Buy Now | 50% | Stifel | Dae Gon Ha48% | $48 → $66 | Maintains | Buy | Get Alert |
| 06/18/2024 | Buy Now | 45.45% | Citigroup | David Lebowitz53% | $38 → $64 | Maintains | Buy | Get Alert |
| 06/18/2024 | Buy Now | -11.36% | JP Morgan | Jessica Fye63% | $31 → $39 | Maintains | Overweight | Get Alert |
| 06/18/2024 | Buy Now | 54.55% | JMP Securities | Jonathan Wolleben68% | $66 → $68 | Maintains | Market Outperform | Get Alert |
| 06/18/2024 | Buy Now | 29.55% | Morgan Stanley | Michael Ulz64% | $53 → $57 | Maintains | Overweight | Get Alert |
| 06/17/2024 | Buy Now | 50% | HC Wainwright & Co. | Ed Arce59% | $58 → $66 | Maintains | Buy | Get Alert |
| 06/17/2024 | Buy Now | 9.09% | Stifel | Dae Gon Ha48% | $48 → $48 | Reiterates | Buy → Buy | Get Alert |
| 06/17/2024 | Buy Now | -11.36% | Baird | Brian Skorney57% | $34 → $39 | Maintains | Outperform | Get Alert |
| 06/07/2024 | Buy Now | 31.82% | HC Wainwright & Co. | Ed Arce59% | $58 → $58 | Reiterates | Buy → Buy | Get Alert |
| 06/03/2024 | Buy Now | 31.82% | HC Wainwright & Co. | — | $58 → $58 | Reiterates | Buy → Buy | Get Alert |
| 05/10/2024 | Buy Now | 20.45% | Morgan Stanley | Michael Ulz64% | $57 → $53 | Maintains | Overweight | Get Alert |
| 05/09/2024 | Buy Now | -9.09% | Cantor Fitzgerald | Josh Schimmer52% | $40 → $40 | Reiterates | Overweight → Overweight | Get Alert |
| 05/09/2024 | Buy Now | 31.82% | HC Wainwright & Co. | Ed Arce59% | $58 → $58 | Reiterates | Buy → Buy | Get Alert |
| 05/09/2024 | Buy Now | 50% | JMP Securities | Jonathan Wolleben68% | $72 → $66 | Maintains | Market Outperform | Get Alert |
| 05/09/2024 | Buy Now | -13.64% | Citigroup | David Lebovitz65% | $37 → $38 | Maintains | Buy | Get Alert |
| 04/17/2024 | Buy Now | 9.09% | Stifel | Dae Gon Ha48% | → $48 | Initiates | → Buy | Get Alert |
| 04/02/2024 | Buy Now | 31.82% | HC Wainwright & Co. | Ed Arce59% | $58 → $58 | Maintains | Buy | Get Alert |
| 03/18/2024 | Buy Now | -2.27% | Leerink Partners | Mani Foroohar47% | $44 → $43 | Maintains | Outperform | Get Alert |
| 03/14/2024 | Buy Now | 63.64% | JMP Securities | Jonathan Wolleben68% | $69 → $72 | Maintains | Outperform | Get Alert |
| 03/14/2024 | Buy Now | 31.82% | HC Wainwright & Co. | Ed Arce59% | $45 → $58 | Maintains | Buy | Get Alert |
| 03/04/2024 | Buy Now | -9.09% | Cantor Fitzgerald | Josh Schimmer52% | $35 → $40 | Maintains | Overweight | Get Alert |
| 02/29/2024 | Buy Now | -20.45% | Cantor Fitzgerald | Josh Schimmer52% | $35 → $35 | Reiterates | Overweight → Overweight | Get Alert |
| 02/29/2024 | Buy Now | 2.27% | HC Wainwright & Co. | Ed Arce59% | $58 → $45 | Maintains | Buy | Get Alert |
| 02/29/2024 | Buy Now | 56.82% | JMP Securities | Jonathan Wolleben68% | $64 → $69 | Maintains | Market Outperform | Get Alert |
| 01/11/2024 | Buy Now | 45.45% | JMP Securities | Jonathan Wolleben68% | $64 → $64 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/19/2023 | Buy Now | 45.45% | Raymond James | Steven Seedhouse58% | $78 → $64 | Maintains | Strong Buy | Get Alert |
| 12/18/2023 | Buy Now | 31.82% | HC Wainwright & Co. | Ed Arce59% | $60 → $58 | Maintains | Buy | Get Alert |
| 11/27/2023 | Buy Now | 13.64% | Cantor Fitzgerald | Josh Schimmer52% | → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 11/20/2023 | Buy Now | -15.91% | JP Morgan | Jessica Fye63% | → $37 | Reinstates | → Overweight | Get Alert |
| 11/15/2023 | Buy Now | 13.64% | Cantor Fitzgerald | Joshua Schimmer43% | → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 11/13/2023 | Buy Now | 36.36% | Morgan Stanley | Michael Ulz64% | → $60 | Initiates | → Overweight | Get Alert |
| 11/03/2023 | Buy Now | 36.36% | HC Wainwright & Co. | Ed Arce59% | $63 → $60 | Maintains | Buy | Get Alert |
| 10/24/2023 | Buy Now | 13.64% | Cantor Fitzgerald | Joshua Schimmer43% | → $50 | Initiates | → Overweight | Get Alert |
| 10/18/2023 | Buy Now | 59.09% | JMP Securities | Jonathan Wolleben68% | → $70 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 10/18/2023 | Buy Now | 75% | Raymond James | Steven Seedhouse58% | $84 → $77 | Maintains | Strong Buy | Get Alert |
| 10/17/2023 | Buy Now | 40.91% | Evercore ISI Group | Gavin Clark-Gartner38% | → $62 | Reinstates | → Outperform | Get Alert |
| 10/09/2023 | Buy Now | 59.09% | JMP Securities | Jonathan Wolleben68% | → $70 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 09/20/2023 | Buy Now | 59.09% | JMP Securities | Jonathan Wolleben68% | → $70 | Initiates | → Market Outperform | Get Alert |
| 09/13/2023 | Buy Now | 43.18% | HC Wainwright & Co. | Ed Arce59% | → $63 | Reiterates | Buy → Buy | Get Alert |
| 08/21/2023 | Buy Now | 90.91% | Raymond James | Steven Seedhouse58% | $79 → $84 | Maintains | Strong Buy | Get Alert |
| 08/04/2023 | Buy Now | 43.18% | HC Wainwright & Co. | Ed Arce59% | → $63 | Reiterates | → Buy | Get Alert |
| 08/04/2023 | Buy Now | 79.55% | Raymond James | Steven Seedhouse58% | $82 → $79 | Maintains | Strong Buy | Get Alert |
| 07/18/2023 | Buy Now | 43.18% | HC Wainwright & Co. | Ed Arce59% | $61 → $63 | Maintains | Buy | Get Alert |
| 07/18/2023 | Buy Now | 86.36% | Raymond James | Steven Seedhouse58% | $81 → $82 | Maintains | Strong Buy | Get Alert |
| 06/15/2023 | Buy Now | 38.64% | HC Wainwright & Co. | Ed Arce59% | → $61 | Reiterates | Buy → Buy | Get Alert |
| 05/22/2023 | Buy Now | 38.64% | HC Wainwright & Co. | Ed Arce59% | → $61 | Reiterates | Buy → Buy | Get Alert |
| 05/05/2023 | Buy Now | 38.64% | HC Wainwright & Co. | Ed Arce59% | → $61 | Reiterates | → Buy | Get Alert |
| 04/13/2023 | Buy Now | 84.09% | Raymond James | Steven Seedhouse58% | $83 → $81 | Maintains | Strong Buy | Get Alert |
| 04/06/2023 | Buy Now | 38.64% | HC Wainwright & Co. | Ed Arce59% | → $61 | Reiterates | → Buy | Get Alert |
| 03/15/2023 | Buy Now | 38.64% | HC Wainwright & Co. | Ed Arce59% | → $61 | Reiterates | → Buy | Get Alert |
| 03/09/2023 | Buy Now | 38.64% | HC Wainwright & Co. | Ed Arce59% | → $61 | Reiterates | → Buy | Get Alert |
| 03/09/2023 | Buy Now | 88.64% | Raymond James | Steven Seedhouse58% | $84 → $83 | Maintains | Strong Buy | Get Alert |
| 02/15/2023 | Buy Now | 38.64% | HC Wainwright & Co. | Ed Arce59% | $69 → $61 | Reiterates | → Buy | Get Alert |
| 01/10/2023 | Buy Now | 90.91% | Raymond James | Steven Seedhouse58% | $88 → $84 | Maintains | Strong Buy | Get Alert |
| 01/10/2023 | Buy Now | -11.36% | SVB Leerink | Mani Foroohar47% | $50 → $39 | Maintains | Outperform | Get Alert |
| 12/14/2022 | Buy Now | 13.64% | SVB Leerink | Mani Foroohar47% | $49 → $50 | Maintains | Outperform | Get Alert |
| 11/14/2022 | Buy Now | 56.82% | HC Wainwright & Co. | Ed Arce59% | $68 → $69 | Maintains | Buy | Get Alert |
| 11/10/2022 | Buy Now | -22.73% | Citigroup | David Lebowitz53% | $38 → $34 | Maintains | Buy | Get Alert |
| 10/25/2022 | Buy Now | 100% | Raymond James | Steven Seedhouse58% | $75 → $88 | Maintains | Strong Buy | Get Alert |
| 10/25/2022 | Buy Now | 54.55% | HC Wainwright & Co. | Ed Arce59% | $63 → $68 | Maintains | Buy | Get Alert |
| 09/01/2022 | Buy Now | -13.64% | Citigroup | David Lebowitz53% | → $38 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Mirum Pharmaceuticals (MIRM) stock?
The latest price target for Mirum Pharmaceuticals (NASDAQ:MIRM) was reported by HC Wainwright & Co. on May 19, 2025. The analyst firm set a price target for $73.00 expecting MIRM to rise to within 12 months (a possible 65.91% upside). 27 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Mirum Pharmaceuticals (MIRM)?
The latest analyst rating for Mirum Pharmaceuticals (NASDAQ:MIRM) was provided by HC Wainwright & Co., and Mirum Pharmaceuticals their buy rating.
When was the last upgrade for Mirum Pharmaceuticals (MIRM)?
There is no last upgrade for Mirum Pharmaceuticals
When was the last downgrade for Mirum Pharmaceuticals (MIRM)?
There is no last downgrade for Mirum Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Mirum Pharmaceuticals (MIRM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mirum Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mirum Pharmaceuticals was filed on May 19, 2025 so you should expect the next rating to be made available sometime around May 19, 2026.
Is the Analyst Rating Mirum Pharmaceuticals (MIRM) correct?
While ratings are subjective and will change, the latest Mirum Pharmaceuticals (MIRM) rating was a with a price target of $0.00 to $73.00. The current price Mirum Pharmaceuticals (MIRM) is trading at is $44.00, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
